Posted by Michael Wonder on 23 Apr 2020
Canada’s Apotex donates two million dosages of hydroxychloroquine to the Public Health Agency of Canada
21 April 2020 - Supply will Support Clinical Trials and be Part of the National Emergency Strategic Stockpile.
As researchers around the globe and across the country accelerate their efforts to study the effectiveness of hydroxychloroquine in treating COVID-19, Apotex, Canada’s largest pharmaceutical company and the only manufacturer of hydroxychloroquine in the country, announced a donation today of two million dosages of the medication to the federal government.
The company shifted priorities several weeks ago to scale up production and repurpose its plants to manufacture even more hydroxychloroquine, while ensuring Canadians currently being treated with the drug for approved indications have continued access.
